| The Role of Histone Demethylase KDM4B in Myc Signaling in Neuroblastoma J Yang, AM AlTahan, D Hu, Y Wang, PH Cheng, CL Morton, C Qu, ... J Natl Cancer Inst 107 (6), 2015 | 78 | 2015 |
| Oncolytic Replication of E1b-Deleted Adenoviruses PH Cheng, SL Wechman, KM McMasters, HS Zhou Viruses 7 (11), 5767-5779, 2015 | 69 | 2015 |
| Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells PH Cheng, S Lian, R Zhao, XM Rao, KM McMasters, HS Zhou Virology journal 10, 1-13, 2013 | 47 | 2013 |
| Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin E PH Cheng, XM Rao, KM McMasters, HS Zhou PloS one 8 (2), e57340, 2013 | 34 | 2013 |
| KDM5A regulates a translational program that controls p53 protein expression D Hu, C Jablonowski, PH Cheng, A AlTahan, C Li, Y Wang, L Palmer, ... Iscience 9, 84-100, 2018 | 24 | 2018 |
| Indole-3-carbinol (I3C) increases apoptosis, represses growth of cancer cells, and enhances adenovirus-mediated oncolysis L Chen, PH Cheng, XM Rao, KM McMasters, HS Zhou Cancer biology & therapy 15 (9), 1256-1267, 2014 | 20 | 2014 |
| Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter PH Cheng, XM Rao, X Duan, XF Li, ME Egger, KM McMasters, HS Zhou Journal of molecular medicine 93, 211-223, 2015 | 16 | 2015 |
| Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice PH Cheng, XM Rao, SL Wechman, XF Li, KM McMasters, HS Zhou BMC Cancer 15 (1), 716, 2015 | 12 | 2015 |
| Development of an Oncolytic Adenovirus with Enhanced Spread Ability through Repeated UV Irradiation and Cancer Selection SL Wechman, XM Rao, PH Cheng, JG Gomez-Gutierrez, KM McMasters, ... Viruses 8 (6), 167, 2016 | 9 | 2016 |
| Preventing packaging of translatable P5-associated DNA contaminants in recombinant AAV vector preps MA Brimble, PH Cheng, SM Winston, IL Reeves, A Souquette, Y Spence, ... Molecular Therapy-Methods & Clinical Development 24, 280-291, 2022 | 8 | 2022 |
| KDM5A Regulates a Translational Program that Controls p53 Protein Expression. iScience, 9, 84–100 D Hu, C Jablonowski, PH Cheng, A AlTahan, C Li, Y Wang, L Palmer, ... | 5 | 2018 |
| Pre-existing immunity to a nucleic acid contaminant-derived antigen mediates transaminitis and resultant diminished transgene expression in a mouse model of hepatic rAAV … M Brimble, CL Morton, SM Winston, IL Reeves, Y Spence, PH Cheng, ... Human Gene Therapy, 2024 | | 2024 |
| Recombinant P5 Promoter for Use in Reducing DNA Contamination of AAV Preparations M BRIMBLE, A Davidoff, PH CHENG, C Morton US Patent App. 17/927,038, 2023 | | 2023 |
| Transcription, Translation, and Immunogenic Potential of P5-Associated rAAV Contaminants Post-Infection MA Brimble, PH Cheng, SM Winston, IL Reeves, A Souquette, Y Spence, ... MOLECULAR THERAPY 30 (4), 204-204, 2022 | | 2022 |
| Oncolytic adenoviral therapy enhanced by targeting cyclin E overexpression and inducing autophagy P Cheng, XM Rao, KM McMasters, HS Zhou Experimental Biology 2013 The FASEB Journal 27 (1_MeetingAbstracts), 1105.4, 2013 | | 2013 |
